Back

The Societal Cost of Alzheimer's Disease depends on the Diagnosis Timing

2026-01-08 health economics Title + abstract only
View on medRxiv
Show abstract

BackgroundAlzheimers disease (AD) is a major public health issue with rising prevalence due to global aging. In France, official estimates report a societal cost of {euro}2.3 billion, however likely underestimating the true economic burden. MethodsA comprehensive economic model was developed to estimate the ADs societal cost in France. The model incorporated diagnosis timings (early, average, late), disease stages (MCI, mild, severe AD), direct and indirect costs, and different payors. Results...

Predicted journal destinations